Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,422,078
+$19,422,078 QoQ
Shares Held
77,182
Ownership
0.004%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#622
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$17,093,843
PutShares
78,596
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOGAN CAPITAL MANAGEMENT INC holds $143,017,458 across 13 Drug Manufacturers - General names. ABBV ranks #3 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,791 | $33,333,361 | |
| 2 | MRK |
Merck & Co., Inc.
|
155,292 | $19,955,022 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
77,182 | $19,422,078 | |
| 4 | JNJ |
Johnson & Johnson
|
62,551 | $15,886,077 | |
| 5 | NVS |
Novartis AG
|
73,584 | $11,532,084 | |
| 6 | SNY |
Sanofi
|
258,642 | $11,033,667 | |
| 7 | PFE |
Pfizer Inc
|
442,396 | $10,652,895 | |
| 8 | GSK |
GSK plc
|
141,076 | $7,395,203 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,422,078 | 77,182 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,093,843 | 78,596 | Put | Other | 2026-05-08 | |
| 2025-12-31 | $18,146,447 | 79,419 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $20,378,066 | 88,011 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,763,712 | 90,312 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $23,906,859 | 114,103 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $19,482,672 | 109,638 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,824,699 | 110,516 | Shares | Other | 2024-12-06 | |
| 2024-06-30 | $18,922,771 | 110,324 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,288,307 | 111,413 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $18,215,328 | 117,541 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,240,918 | 122,373 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,587,182 | 115,692 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,083,713 | 113,470 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $19,085,493 | 118,096 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,846,582 | 88,269 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,558,182 | 88,523 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $16,264,820 | 100,332 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,309,748 | 105,685 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,683,075 | 108,307 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,431,607 | 101,488 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $10,968,312 | 101,352 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,854,080 | 101,298 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $9,846,779 | 112,419 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,486,862 | 116,998 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $10,313,991 | 135,372 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||